walking

January 3, 2018January 3, 2018

Tailored Approaches May Lead to More Effective MS Treatments, UCLA Study Shows

News

Tailored molecular treatments for specific disabilities may be a breakthrough for multiple sclerosis (MS) patients, finds a new study by researchers at University of California-Los Angeles (UCLA). ... Read more

October 26, 2017October 26, 2017

#MSParis2017 – Tysabri Did Improve Walking and Hand Function in Failed SPMS Trial, Researchers Say

News

While Tysabri (natalizumab) failed to slow worsening disability in people with secondary progressive multiple sclerosis (SPMS) in a Phase 3 trial, researchers now suggest that the ... Read more

October 2, 2017October 2, 2017

Combating Muscle Weakness Associated with MS

Columns, Faith of the Mustard Seed - a Column by Debi Wilson

Sometimes walking, even with an assistance device, can be very challenging because of the extreme muscle weakness that I experience. The slow, off-balanced gait that has ... Read more

August 11, 2017August 10, 2017

Walk This Way

Columns, Fall Down, Get Up Again- a Column by John Connor

As I write, I’m pain-free. This is important, but not for the obvious reason. I’m pain-free and can walk — or at least stumble — about as ... Read more

July 11, 2017July 17, 2017

Long-term Use of Ampyra Lowers Medical Costs, Hospital Visits for MS Patients, Study Finds

News

A recent study has found that continued use of Ampyra (dalfampridine extended-release, sold in the U.S. by Acorda Therapeutics) by patients with multiple sclerosis (MS) lowers ... Read more

July 10, 2017July 11, 2017

How to Improve MS-Related Imbalance

Columns, Faith of the Mustard Seed - a Column by Debi Wilson

One of the earliest symptoms that appeared before my multiple sclerosis (MS) diagnosis was imbalance. I remember turning my head to look at something and feeling ... Read more

July 7, 2017July 11, 2017

New Ocrevus Findings Show Benefits to Range of MS Patients: Interview with Genentech’s Dr. Hideki Garren

News

Genentech shared new insights into the workings of Ocrevus (ocrelizumab) and its effectiveness in reducing disease activity and slowing progression in relapsing and primary progressive multiple ... Read more

July 6, 2017July 6, 2017

Lipoic Acid, an Over-the-counter Antioxidant, Seen to Slow Brain Atrophy in SPMS Patients

News

The over-the-counter antioxidant lipoic acid slowed brain deterioration in patients with secondary progressive multiple sclerosis (SPMS), according to a pilot study. An Oregon Health & Science University ... Read more

June 27, 2017June 26, 2017

If My MRI Is Stable, Why Is My Walking Getting Worse?

Columns, The MS Wire - A Column by Ed Tobias

During a routine exam with my neurologist recently, I asked her a question I’d never thought to ask before: “Why do you order regular MRIs of ... Read more

June 13, 2017June 12, 2017

Life Lessons from Children: Fall Down, Get Up and Don’t Stop Trying

Columns, Patiently Awakened - A Column by Teresa Wright-Johnson

I have had the privilege of watching several children grow into adulthood, and witnessing their transformation has been priceless. I have experienced extreme joy, sorrow, pride, and ... Read more

May 25, 2017May 25, 2017

Fampyra Granted Standard Approval in Europe as Trial Results Support Effectiveness

News

Fampyra (prolonged-release fampridine tablets) — sold in the U.S. as Ampyra (dalfampridine) — has now been granted standard marketing authorization in Europe. The approval was based ... Read more

May 22, 2017May 20, 2017

A Walk in the Park Reminds Me That I Am Not Alone

Columns, Faith of the Mustard Seed - a Column by Debi Wilson

My walk in the park usually consists of watching every one of my steps, while conserving my energy so I can finish the trek. In the ... Read more

April 10, 2017April 10, 2017

Ampyra Aided Walking in PPMS and RMS Patients Over Long Term, Neurologist Says in Interview

News

Ampyra (dalfampridine) shows long-term efficacy in improving walking ability in people with multiple sclerosis, according to a study evaluating the treatment’s use in progressive and relapsing MS patients ... Read more

April 10, 2017April 10, 2017

Transcript of Interview on Ampyra Research, MS Walking Ability and Long-Term Use

News

Multiple Sclerosis News Today interviewed Dr. Linard Filli,
 an MS researcher at the University Hospital Zurich involved in clinical studies of prolonged release Ampyra (dalfampridine), on walking ability ... Read more

March 24, 2017March 24, 2017

History Conjures Up Electricity-Aided Walking, but a Too-Daring Pilot

Columns, Fall Down, Get Up Again- a Column by John Connor

It seems I’ve made it to my second weekly column. I was going to write about a non-MS physical impairment that had kept me down for ... Read more

March 15, 2017March 15, 2017

Walk In, Roll Out: The Conundrum of Cardio Exercise with MS

Columns, Make Change Happen - A Column by Paula Hardin

In pursuit of an answer for breathing difficulty The MRI of my cervical and thoracic spine showed no active lesions last week. That was good news. ... Read more

September 20, 2016September 20, 2016

#ECTRIMS2016 – MS Patients Achieve Sustained Improvements in Mobility with Ampyra

News

A recent study showed that the clinical benefits offered by Ampyra (fampridine) in improving mobility among multiple sclerosis (MS) patients has clinical significance. The results were shown ... Read more

March 18, 2016March 18, 2016

Resistance Training in Ms Patients Found to Improve Hip Strength, Walking Ability

News

Researchers at the Kennedy Krieger Institute and Johns Hopkins University School of Medicine released preliminary results of an ongoing study into an effective and progressive resistance training program ... Read more

March 3, 2016March 3, 2016

MSAA Draws Attention to Specific Multiple Sclerosis Symptoms Each Week of March, MS Awareness Month

News

March is Multiple Sclerosis (MS) Awareness Month, and the  Multiple Sclerosis Association of America (MSAA) will be marking it with a campaign to educate and heighten public ... Read more

February 23, 2016February 23, 2016

Science Fiction Becomes Reality for MS Patients in New Robotic Exoskeleton Study

News

Wearable robotic exoskeletons may soon help people with advanced multiple sclerosis (MS) walk more efficiently and confidently again. Exoskeleton technology reduces the amount of energy and ... Read more

December 22, 2015December 22, 2015

MS Patients Show Better Gait and Balance with Dalfampridine Treatment

News

In a new study, researchers evaluated the effect of dalfampridine treatment in people with multiple sclerosis (MS) and observed significant improvements in not only walking speed ... Read more